Skip to main content
Equibles
TRDA logo

TRDA · Entrada Therapeutics, Inc. · Fails to Deliver

Track TRDA — free

Use TRDA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TRDA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.17 -0.27 (-4.96%) At close · Nov 12 Play latest call Q1 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Nov 5, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result of our recurring losses from operations and recurring negative cash flows from operations, there is substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Nov 5, 2026
Market Cap
$202.41M
Shares
39.15M
Volume · Nov 12 808.67K Avg daily vol (3M) 365.68K

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Pull fails-to-deliver data for any ticker through the FTD API or MCP →
1M 3M 6M 1Y 5Y All

Fails to Deliver History

Settlement Date Quantity Price Value
2026-10-05 47,862 $5.38 $257,498
2026-09-04 279 $7.17 $2,000
2026-08-19 177 $7.27 $1,287
Showing 1–3 of 3 settlements
Key facts CIK 1689375 CUSIP 29384C108 13F (30d) 70 filings 57 filers Visit website Investor relations